|1.||Aung, Tin: 1 article (11/2015)|
|2.||Wang, Ningli: 1 article (11/2015)|
|3.||Zhang, Xiulan: 1 article (11/2015)|
|4.||Wang, Wei: 1 article (11/2015)|
|5.||Jonas, Jost B: 1 article (11/2015)|
|6.||Chosidow, O: 1 article (07/2015)|
|7.||Gonçalo, M: 1 article (07/2015)|
|8.||Cazzaniga, S: 1 article (07/2015)|
|9.||Hercogova, J: 1 article (07/2015)|
|10.||Pigatto, P D: 1 article (07/2015)|
|1.||Crohn Disease (Crohn's Disease)
03/01/2000 - "The relative incidence of PACD in Crohn's disease patients ranges from 15 to 80% in the literature, depending on the accuracy of the clinical investigations and the clinical importance attributed to the lesions in the various study populations. "
04/01/2015 - "We screened for sphincter defects and the presence of perianal Crohn's disease (PACD)-related lesions. "
03/01/2000 - "Perianal Crohn's disease (PACD) is defined as the presence of persistent lesions in the anal canal and perianal region in patients with Crohn's disease. "
07/01/1992 - "We studied 40 patients with perianal Crohn's disease (PACD), 14 patients with anal disease not related to Crohn's disease, and 10 normal individuals. "
08/01/2013 - "There are limited data concerning the clinical value of transperineal ultrasound (TP-US) in both cryptogenic fistula-in-ano and perianal Crohn's disease (PACD). "
05/01/2015 - "Acute heart failure was induced in all animals, and the hemodynamic effects of PACD were then reassessed. "
12/01/2003 - "In an acute heart failure model, the IABP was placed in the descending aorta and the PACD in the ascending aorta of eight pigs. "
12/01/2003 - "The purpose of this study was to compare the hemodynamic effectiveness of a 30-ml stroke volume paraaortic counterpulsation device (PACD), presenting the advantages of ease of implantation and driving by a standard intraaortic balloon pump (IABP) console (Datascope 96, Datascope Corp., Montvale, NJ, USA) to that of a 40-ml IABP, in the setting of experimental heart failure. "
03/01/2012 - "Para-aortic counterpulsation device (PACD) is a promising therapy for severe heart failure (HF). "
07/01/1990 - "The hemodynamic effects of the combined use of the paraaortic counterpulsation device (PACD) (stroke volume 65 ml) implanted on the ascending aorta, and a 20 ml intraaortic balloon pump (IABP) placed in the descending aorta, were compared with the PACD working alone in 12 dogs after the induction of heart failure. "
03/01/1997 - "In this study the hemodynamic effects of the valveless PACD were compared to those of the centrifugal blood pump (CBP) in nine dogs in acute experimental cardiogenic shock. "
03/01/1997 - "It was concluded that PACD is at least as effective as CBP for restoring hemodynamic status during acute experimental cardiogenic shock. "
12/01/2003 - "The purpose of this study was to evaluate the performance of 2 tests: Peripheral Anterior Chamber Depth (PACD) measurement and Central Anterior Chamber Depth (CACD) measurement in detecting occludable angles and primary angle closure within subjects with primary glaucoma and control subjects. "
12/01/2003 - "Among subjects with no glaucoma, PACD gradings 0 to 2 correctly identified 12 out of the 14 eyes with gonioscopically occludable angles, while the test identified 238 eyes without occludable angles, gonioscopy identified 236 out of 250 of such eyes. "
|5.||Asthma (Bronchial Asthma)
05/01/2001 - "These validity studies suggest that diary questionnaires such as the PAD and PACD can be valuable as an alternative for the evaluation of interventions in pediatric asthma when pulmonary function testing is inappropriate or as an adjunct to such objective measures."
05/01/2001 - "Only the PACD detected differences between groups in nighttime symptoms, such as awakenings caused by asthma. "
05/01/2001 - "Two pediatric diary questionnaires (the child-completed Pediatric Asthma Diary [PAD] and the parent/caregiver-completed Pediatric Asthma Caregiver Diary [PACD]) were designed to evaluate asthma symptoms in children aged 6 to 14 years and 2 to 5 years, respectively. "
|1.||Complementary DNA (cDNA)
|2.||Sunscreening Agents (Sunscreens)
|4.||Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
|1.||Counterpulsation (External Counterpulsation)